The final, formatted version of the article will be published soon.
REVIEW article
Front. Pediatr.
Sec. Pediatric Cardiology
Volume 13 - 2025 |
doi: 10.3389/fped.2025.1506690
This article is part of the Research Topic Challenges and Innovations in Managing Complications of Fontan Circulation View all articles
Arrhythmias in Patients after Fontan completion: Review of Current Literature, Management, and Surveillance
Provisionally accepted- 1 University of Alabama at Birmingham, Birmingham, Alabama, United States
- 2 Seattle Children's Hospital, Seattle, Washington, United States
- 3 Other, Portland, United States
- 4 Oregon Health and Science University, Portland, Oregon, United States
Purpose The Fontan operation is commonly associated with arrythmias, both tachycardic and bradycardic. Despite modifications to attempt to mitigate these complications, arrythmias still frequently occur. The purpose of this review is to examine the literature regarding the scope of the problem, therapeutic options, and current recommendations regarding screening and surveillance. Recent Findings Modifications to the original Fontan procedure, antiarrhythmic medications, and improvements in catheter ablation procedures have improved the management of patients with arrhythmias following Fontan palliation. There is growing interest in the role of junctional rhythm in the role of Fontan dysfunction. While chronotropic incompetence has often been blamed for poor exercise testing, there is evidence that decreased performance may be related to ventricular filling and Fontan hemodynamics. Summary Tachyarrhythmias are an important cause of mortality and morbidity after the Fontan operation. Prompt and aggressive management of arrhythmias with the goal of maintaining sinus rhythm is vital. Management strategies such as anti-arrhythmic medications, ablation, anti-tachycardia pacing and Fontan conversion should be seen as complementary and used early to prevent hemodynamic deterioration. Bradyarrythmias likely also contribute to Fontan failure. Pacing is the primary management strategy with evidence supporting use of atrial pacing. However, ventricular pacing seems to often lead to deleterious effects. Current guidelines recommend surveillance with Holter monitor every 2-3 years in adolescents and every 1-2 years in adults. Future directions for research include further assessment of junctional rhythm and its management as well as further identifying patients in which pacing would be beneficial.
Keywords: Fontan, Junctional Rhythm, Tachyarhythmia, antiarrhyhtmic drugs, arrhythmia < cardiovascular, surveillance
Received: 05 Oct 2024; Accepted: 20 Jan 2025.
Copyright: © 2025 Wall, Hebson, D'Souza and Balaji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Seshadri Balaji, Other, Portland, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.